JVACX
Price
$40.51
Change
+$0.03 (+0.07%)
Updated
Jul 13 closing price
Net Assets
8.61B
RMFCX
Price
$63.84
Change
-$0.19 (-0.30%)
Updated
Jul 13 closing price
Net Assets
118.05B
Interact to see
Advertisement

JVACX vs RMFCX

JVACX vs RMFCX Comparison Chart in %
View a ticker or compare two or three
VS
JVACX vs. RMFCX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVACX is a Buy and RMFCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 118B vs. JVACX (8.61B). RMFCX pays higher dividends than JVACX: RMFCX (1.16) vs JVACX (0.51). JVACX was incepted earlier than RMFCX: JVACX (21 years) vs RMFCX (24 years). JVACX (1.62) is less costly to investors than RMFCX (0.91). JVACX is a more actively managed with annual turnover of: 36.00 vs. RMFCX (30.00). RMFCX has a lower initial minimum investment than JVACX: RMFCX (250) vs JVACX (1000). RMFCX annual gain was more profitable for investors over the last year : 8.88 vs. JVACX (4.58). RMFCX return over 5 years is better than : 37.23 vs. JVACX (-2.94).
JVACXRMFCXJVACX / RMFCX
Total Expense Ratio1.490.91164%
Annual Report Gross Expense Ratio1.620.91178%
Fund Existence21 years24 years-
Gain YTD11.7619.137129%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets8.61B118B7%
Annual Yield % from dividends0.511.1644%
Returns for 1 year4.588.8852%
Returns for 3 years17.2434.8449%
Returns for 5 years-2.9437.23-8%
Returns for 10 years46.1091.0651%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DIFCX12.85N/A
N/A
MFS Diversified Income C
MIEGX15.36N/A
N/A
BNY Mellon Emerging Markets Inv
SBHIX27.57N/A
N/A
Saratoga Health & Biotechnology I
MRGRX59.48N/A
N/A
MFS Core Equity I
WGICX10.23N/A
N/A
Wasatch Micro Cap Institutional